Hunan Fangsheng Pharmaceutical Co.,Ltd.’s Net Profit Rose 115.2% in First Half of 2023

Hunan Fangsheng Pharmaceutical Co.,Ltd. (湖南方盛制药股份有限公司) (603998.SH) reported a net profit of 106.1 million yuan in the first half of 2023, up 115.2% year-on-year.

Meanwhile, the company posted 855.2 million yuan in revenue, down 2.1% year-on-year.

At the end of the reporting period, it had 3 billion yuan in total assets and 1.5 billion yuan in total liabilities, with a liability-to-asset ratio of 49.8%.